Preventing death in the catastrophic antiphospholipid (Asherson) syndrome.
García-Carrasco
Mario
M
Systemic Autoimmune Disease Research Unit, HGR#36, Instituto Mexicano del Seguro Social, Puebla, México. 30591mgc@comb.es
Escárcega
Ricardo O
RO
Mendoza-Pinto
Claudia
C
Zamora-Ustaran
Alfonso
A
Etchegaray-Morales
Ivet
I
Rojas-Rodriguez
Jorge
J
Escobar-Linares
Luis E
LE
Cervera
Ricard
R
D000328:Adult; D000465:Algorithms; D016736:Antiphospholipid Syndrome / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D015897:Comorbidity; D003422:Critical Care; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000453:epidemiology; D008775:Methylprednisolone / Q000627:therapeutic use
D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D008775:Methylprednisolone